152 related articles for article (PubMed ID: 37538110)
1. Bevacizumab-loaded CalliSpheres beads:
Ren K; Li Y; Zhou Z; Wu K; Wang J; Yao J; Li Y; Ge X; Li X; Li Z; Li Z; Han X
Front Oncol; 2023; 13():1153759. PubMed ID: 37538110
[TBL] [Abstract][Full Text] [Related]
2. Apatinib-loaded CalliSpheres Beads for embolization in a rabbit VX2 liver tumor: characterization
Shi Q; Lu Y; Huang S; Zhou C; Yang C; Liu J; Ma J; Xiong B
Drug Deliv; 2020 Dec; 27(1):1301-1307. PubMed ID: 32924634
[TBL] [Abstract][Full Text] [Related]
3. Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization.
Li T; Shi Q; Liu J; Wang Y; Zhou C; Wang C; Ju S; Huang S; Yang C; Chen Y; Bai Y; Xiong B
J Hepatocell Carcinoma; 2021; 8():1525-1535. PubMed ID: 34888263
[TBL] [Abstract][Full Text] [Related]
4. Loadability and Releasing Profiles
Wang H; Wang J; Lv T; Cao S; Tong X; Song L; Zou Y
Cancer Biother Radiopharm; 2023 Oct; 38(8):536-542. PubMed ID: 32614660
[No Abstract] [Full Text] [Related]
5. Antitumor properties of arsenic trioxide-loaded CalliSpheres
Duan X; Li H; Han X; Ren J; Li F; Ju S; Wang M; Wang W
Am J Transl Res; 2020; 12(9):5511-5524. PubMed ID: 33042434
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma.
Liu H; Li Y; Li Z; Han X; Ren K
Front Pharmacol; 2023; 14():1170344. PubMed ID: 37284322
[No Abstract] [Full Text] [Related]
7. The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer.
Bi Y; Li F; Ren J; Han X
Front Pharmacol; 2022; 13():1079707. PubMed ID: 36518678
[No Abstract] [Full Text] [Related]
8. Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology.
Sakr OS; Berndt S; Carpentier G; Cuendet M; Jordan O; Borchard G
J Control Release; 2016 Feb; 224():199-207. PubMed ID: 26780173
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-loaded CalliSpheres:
Duan X; Zhao G; Han X; Ren J; Li H; Chen P; Wang M; Ju S
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982781
[TBL] [Abstract][Full Text] [Related]
10. Pirarubicin-loaded CalliSpheres® drug-eluting beads for the treatment of patients with stage III-IV lung cancer.
Bi Y; Shi X; Yi M; Han X; Ren J
Acta Radiol; 2022 Mar; 63(3):311-318. PubMed ID: 33615822
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Irinotecan Loading and Releasing Profiles of a Novel Drug-Eluting Microsphere (CalliSpheres)
Chen Q; Sun Y; Dai H; Guo P; Hou S; Sha X
Cancer Biother Radiopharm; 2023 Oct; 38(8):521-527. PubMed ID: 32960076
[No Abstract] [Full Text] [Related]
12. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
Deng G; Zhao DL; Li GC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
[TBL] [Abstract][Full Text] [Related]
13. Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis.
Bi Y; Jiao D; Wang Y; Han X; Ren J
World J Surg Oncol; 2022 Jul; 20(1):229. PubMed ID: 35821043
[TBL] [Abstract][Full Text] [Related]
14. One-step fabrication of lidocaine/CalliSpheres
Tian C; Wang Z; Huang L; Liu Y; Wu K; Li Z; Han B; Jiao D; Han X; Zhao Y
J Transl Med; 2022 Oct; 20(1):463. PubMed ID: 36221084
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study.
Bi Y; Zhang B; Ren J; Han X; Wu W
Front Pharmacol; 2022; 13():992526. PubMed ID: 36249775
[No Abstract] [Full Text] [Related]
16. The effect of sequential transcatheter arterial chemoembolization (TACE) and portal venous embolizations (PVE) vs. TACE or PVE alone on rabbit VX2 liver carcinoma and on liver regeneration.
Guo WC; He XF; Li YH; Li ZH; Mei QL; Chen Y
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3186-93. PubMed ID: 27466990
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads.
Bi Y; Shi X; Ren J; Yi M; Han X
Sci Rep; 2022 May; 12(1):8136. PubMed ID: 35581365
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.
Liang B; Zhao D; Liu Y; Guo X; Zhang H; Zhang L; Zheng C
Drug Deliv Transl Res; 2020 Feb; 10(1):185-191. PubMed ID: 31482517
[TBL] [Abstract][Full Text] [Related]
19. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of transcatheter arterial chemoembolization combined with sorafenib in inhibiting tumor angiogenesis in a rabbit VX2 liver cancer model.
Li W; Kong S; Su J; Huang J; Xue H
J Interv Med; 2020 Feb; 3(1):27-33. PubMed ID: 34805902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
